Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: TruCov based three products
1. TruCov-Breath
2. TruCov-Saliva
3. TruCov-Flow: This is a diagnostic validation study, way we
do testing for COVID-19 within 15-30 seconds using breath (C
Sponsors
Neuome Technologies Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects aged 05-75 years of age and of either sex 2. Subjects who are willing to give consent to the study 3. Mild to moderate COVID-19 clinical symptoms and not confirmed by the any current recommended COVID-19 test 4. Can take oral medicines 5. Subject willing to abide by and comply with the study protocol
Exclusion criteria
Exclusion criteria: 1. Volunteers who are in ICU or unconscious or unable to give breath samples. 2. History of having received or participated in any other similar clinical trial in the last 24 hrs or currently ongoing. 3. Any condition that in the opinion of the investigator does not justify the patientââ?¬•s inclusion for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ââ?¬Â¢ Development of all the parameters including sensitivity and specificity ââ?¬Â¢ Percentage difference in the positivity and negativity of COVID-19 results between Invasive and non-invasive COVID-19 testing method Timepoint: Base line and day 3 | — |
Secondary
| Measure | Time frame |
|---|---|
| ââ?¬Â¢ Design and development of assay instrument. ââ?¬Â¢ Clinical sensitivity and specificity Timepoint: Base line and Day 3 | — |
Countries
India
Contacts
Public ContactDr Rajani Kanth Vangala
Research Consultancy
Outcome results
None listed